Schrodinger Cash Flow from Investing Activities 2019-2023 | SDGR
Schrodinger cash flow from investing activities from 2019 to 2023. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
| Schrodinger Annual Cash Flow Investing (Millions of US $) |
|
|---|---|
| 2023 | $193 |
| 2022 | $90 |
| 2021 | $-17 |
| 2020 | $-382 |
| 2019 | $-54 |
| 2018 | $11 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.690B | $0.217B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $36.755B | 20.18 |
| Inspire Medical Systems (INSP) | United States | $4.712B | 0.00 |
| Axonics (AXNX) | United States | $3.441B | 0.00 |
| 10x Genomics (TXG) | United States | $3.165B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.092B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.951B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.949B | 0.00 |
| Enovis (ENOV) | United States | $2.880B | 21.34 |
| Azenta (AZTA) | United States | $2.763B | 155.30 |
| Privia Health (PRVA) | United States | $2.154B | 120.33 |
| Omnicell (OMCL) | United States | $1.391B | 48.06 |
| Phreesia (PHR) | United States | $1.251B | 0.00 |
| Standard BioTools (LAB) | United States | $0.737B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.668B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.643B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.505B | 0.00 |
| Talkspace (TALK) | United States | $0.484B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.404B | 0.00 |
| Pulmonx (LUNG) | United States | $0.346B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.303B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.212B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.207B | 0.00 |
| Outset Medical (OM) | United States | $0.181B | 0.00 |
| American Well (AMWL) | United States | $0.148B | 0.00 |
| TruBridge (TBRG) | United States | $0.132B | 7.10 |
| MSP Recovery (LIFW) | United States | $0.113B | 0.00 |
| 111 (YI) | China | $0.110B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.073B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.068B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.063B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.057B | 0.00 |
| Augmedix (AUGX) | United States | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Zepp Health (ZEPP) | China | $0.053B | 0.00 |
| Movano (MOVE) | United States | $0.041B | 0.00 |
| Akili (AKLI) | United States | $0.035B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.032B | 0.00 |
| CareCloud (CCLD) | United States | $0.030B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Syra Health (SYRA) | United States | $0.011B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Transgenomic (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |